Gujarat Alkalies and Chemicals quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	1,245	1,105	+12.6%
EBITDA	222	117	+90.1%
EBITDA margin	17.8%	10.6%	+7.3 pts
Profit before tax	110	9.6	+1,052.3%
Net profit	55.0	−13.8	—
EPS	₹7.49	−₹1.88	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	1,245	1,125	1,044	1,083	1,105	1,075	1,029	991	977	1,002	921	971	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	7.7	18.4	30.5	59.3	8.5	24.4	15.2	49.3	3.3	2.5	4.7	71.0
	1,253	1,144	1,075	1,142	1,114	1,100	1,045	1,040	981	1,004	926	1,042
	412	362	352	433	418	412	376	421	430	415	388	448
	2.2	17.9	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0
	−37.0	9.5	4.5	−3.0	21.3	−16.3	22.1	−20.7	−10.3	6.7	3.8	−26.6
	96.7	84.3	87.1	110	88.8	81.2	63.1	71.0	68.8	67.7	65.4	65.3
	16.2	15.5	18.5	15.8	13.7	18.2	10.4	11.1	10.9	12.1	11.2	10.8
	103	105	104	104	102	97.2	98.3	100	96.7	96.7	96.0	95.2
	549	542	496	469	461	480	470	445	415	483	457	439
	1,143	1,135	1,062	1,129	1,104	1,077	1,040	1,027	1,011	1,082	1,021	1,032
	222	110	105	73.9	117	114	98.0	74.9	73.8	28.9	7.3	45.2
	119	5.4	0.6	−30.0	14.8	16.5	−0.3	−25.2	−22.9	−67.9	−88.7	−50.0
Profit
	110	8.3	12.6	13.5	9.6	22.8	4.5	13.0	−30.4	−77.4	−95.3	10.3
	110	8.3	12.6	13.5	9.6	22.8	4.5	13.0	−30.4	−77.4	−95.3	10.3
	17.4	−0.8	−2.1	2.3	1.6	0.9	0.0	0.0	0.0	−0.5	−0.8	−0.1
	39.3	1.2	25.9	−5.1	0.1	0.5	−4.1	2.4	−5.8	−55.7	−6.6	0.0
	56.6	0.4	23.8	−2.8	1.8	1.4	−4.1	2.4	−5.8	−56.2	−7.4	−0.1
	1.6	7.1	−8.8	0.1	−21.6	−12.6	−19.8	−28.8	−19.8	−25.0	−27.3	−28.7
	55.0	15.0	−20.0	16.3	−13.8	8.8	−11.2	−18.2	−44.5	−46.2	−115	−18.4
	53.4	7.9	−11.2	16.3	7.8	21.4	8.6	10.6	−24.7	−21.2	−87.9	10.3
	134	−296	−78.5	−189	203	−254	−260	−64.4	339	105	132	10.1
	189	−281	−98.5	−173	190	−245	−271	−82.6	294	58.8	16.9	−8.2
	—	15.0	−20.0	—	−13.8	—	—	—	—	−46.2	—	—
Per share
	₹7.49	₹2.04	−₹2.72	₹2.23	−₹1.88	₹1.20	−₹1.53	−₹2.48	−₹6.06	−₹6.29	−₹15.68	−₹2.50
	₹7.49	₹2.04	−₹2.72	₹2.23	−₹1.88	₹1.20	−₹1.53	−₹2.48	−₹6.06	−₹6.29	−₹15.68	−₹2.50
Other comprehensive income — detail
	134	−296	−78.5	−189	203	−254	—	—	—	—	—	—
	154	−345	−91.8	−229	238	−310	−304	−54.5	383	118	139	5.3
	19.1	−48.3	−13.3	−40.2	34.2	−55.8	—	—	—	—	—	—
	—	—	—	—	—	—	−44.0	9.9	43.7	13.5	7.1	−4.9
	−1.7	0.2	—	—	—	—	—	—	—	—	—	—
	−0.6	0.1	0.0	0.0	0.0	—	—	—	—	—	—	—
Per share — as-filed variants
	₹7.49	₹2.04	−₹2.72	₹2.23	−₹1.88	₹1.20	−₹1.53	−₹2.48	−₹6.06	−₹6.29	−₹15.68	−₹2.50
	₹7.49	₹2.04	−₹2.72	₹2.23	−₹1.88	₹1.20	−₹1.53	−₹2.48	−₹6.06	−₹6.29	−₹15.68	−₹2.50
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	867	736	688	653	666	675	631	591	558	580	529	549
	69.7%	65.4%	65.9%	60.3%	60.3%	62.8%	61.3%	59.6%	57.1%	57.9%	57.5%	56.6%
Adjusted (ex-exceptional items) — derived
	110	8.3	12.6	13.5	9.6	22.8	4.5	13.0	−30.4	−77.4	−95.3	10.3
	55.0	15.0	−20.0	16.3	−13.8	8.8	−11.2	−18.2	−44.5	−46.2	−115	−18.4
	₹7.49	₹2.04	−₹2.72	₹2.23	−₹1.88	₹1.20	−₹1.53	−₹2.48	−₹6.06	−₹6.29	−₹15.68	−₹2.50

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GUJALKALI₹544.00

Gujarat Alkalies and Chemicals Limited

· Chemicals

Annual Quarterly₹ CrorePeersYASHO EPIGRAL FOSECOIND FCL VISHNU TATVA GALAXYSURF JUBLCPLMcap ₹3,995 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	971.3	920.9	1,001.6	977.3	990.7	1,029.4	1,075.5	1,105.1	1,083.2	1,044.5	1,125.3	1,244.9
Other Income	71.0	4.7	2.5	3.3	49.3	15.2	24.4	8.5	59.3	30.5	18.4	7.7
Total Income	1,042.3	925.6	1,004.2	980.6	1,040.0	1,044.6	1,099.9	1,113.6	1,142.5	1,074.9	1,143.7	1,252.6
Expenses
+ Cost of Materials Consumed	448.4	387.8	415.1	429.6	420.8	376.1	412.3	417.8	433.1	351.9	361.6	412.5
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	17.9	2.2
+ Changes in Inventories	-26.6	3.8	6.7	-10.3	-20.7	22.1	-16.3	21.3	-3.0	4.5	9.5	-37.0
+ Employee Benefit Expense	65.3	65.4	67.7	68.8	71.0	63.1	81.2	88.8	110.3	87.1	84.3	96.7
+ Finance Costs	10.8	11.2	12.1	10.9	11.1	10.4	18.2	13.7	15.8	18.5	15.5	16.2
+ Depreciation & Amortisation	95.2	96.0	96.7	96.7	100.1	98.3	97.2	101.9	103.9	104.2	104.5	103.1
+ Other Expenses	439.0	456.6	483.3	415.5	444.7	470.1	480.5	460.6	468.9	496.3	542.1	548.8
Total Expenses	1,032.1	1,020.9	1,081.6	1,011.0	1,027.0	1,040.1	1,077.2	1,104.0	1,129.0	1,062.3	1,135.4	1,142.5
EBITDA	45.2	7.3	28.9	73.8	74.9	98.0	113.8	116.6	73.9	104.8	109.9	221.7
EBIT	-50.0	-88.7	-67.9	-22.9	-25.2	-0.3	16.5	14.8	-30.0	0.6	5.4	118.6
Profit
PBT before Exceptional Items	10.3	-95.3	-77.4	-30.4	13.0	4.5	22.8	9.6	13.5	12.6	8.3	110.0
Pretax Income	10.3	-95.3	-77.4	-30.4	13.0	4.5	22.8	9.6	13.5	12.6	8.3	110.0
+ Current Tax	-0.1	-0.8	-0.5	0.0	0.0	0.0	0.9	1.6	2.3	-2.1	-0.8	17.4
+ Deferred Tax	0.0	-6.6	-55.7	-5.8	2.4	-4.1	0.5	0.1	-5.1	25.9	1.2	39.3
Tax Expense	-0.1	-7.4	-56.2	-5.8	2.4	-4.1	1.4	1.8	-2.8	23.8	0.4	56.6
+ Share of Associates & JVs	-28.7	-27.3	-25.0	-19.8	-28.8	-19.8	-12.6	-21.6	0.1	-8.8	7.1	1.6
Net Income	-18.4	-115.1	-46.2	-44.5	-18.2	-11.2	8.8	-13.8	16.3	-20.0	15.0	55.0
+ Net Income — Continuing Ops	10.3	-87.9	-21.2	-24.7	10.6	8.6	21.4	7.8	16.3	-11.2	7.9	53.4
+ Other Comprehensive Income	10.1	132.0	105.0	339.0	-64.4	-259.8	-253.9	203.4	-189.1	-78.5	-296.0	134.2
Total Comprehensive Income	-8.2	16.9	58.8	294.5	-82.6	-271.0	-245.1	189.6	-172.7	-98.5	-281.0	189.1
Net Income to Common	—	—	-46.2	—	—	—	—	-13.8	—	-20.0	15.0	—
Per Share
Basic EPS	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49
Diluted EPS	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-253.9	203.4	-189.1	-78.5	-296.0	134.2
+ Items NOT to be Reclassified to P&L	5.3	139.0	118.5	382.7	-54.5	-303.8	-309.7	237.6	-229.3	-91.8	-344.5	154.4
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-55.8	34.2	-40.2	-13.3	-48.3	19.1
+ Tax on Items NOT to be Reclassified — alt tag	-4.9	7.1	13.5	43.7	9.9	-44.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	—	—	—	—	—	—	—	—	0.2	-1.7
+ Tax on Items to be Reclassified	—	—	—	—	—	—	—	0.0	0.0	0.0	0.1	-0.6
Per Share — as-filed variants
Basic EPS — Continuing Operations	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49
Diluted EPS — Continuing Operations	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	549.5	529.3	579.9	558.1	590.6	631.2	675.4	666.0	653.1	688.1	736.3	867.1
Gross Margin %	56.57	57.47	57.89	57.10	59.61	61.32	62.80	60.26	60.29	65.88	65.43	69.65
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	10.3	-95.3	-77.4	-30.4	13.0	4.5	22.8	9.6	13.5	12.6	8.3	110.0
Net Income Adj (tax-effected)	-18.4	-115.1	-46.2	-44.5	-18.2	-11.2	8.8	-13.8	16.3	-20.0	15.0	55.0
EPS Adj	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	73.4	73.4	73.4	73.4	73.4	73.4	73.4	73.4	73.4	73.4	73.4	73.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Gujarat Alkalies and Chemicals Q2 FY27 results date

Gujarat Alkalies and Chemicals (NSE: GUJALKALI) will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, according to the board-meeting notice it filed on 26 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹55 crore, against a loss of ₹13.8 crore in Q1 FY26 and up 267.0% from ₹15 crore in Q4 FY26. Revenue from operations was ₹1,245 crore, up 12.6% year on year and up 10.6% from the previous quarter.

Board-meeting notice filed: 26 October 2026
Q2 FY26 results (a year earlier): 7 November 2025
Q1 FY27 results (the latest): 23 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 5 November 2026Thursday · notice filed 26 Oct
Q1 FY27 net profit: ₹55 Crloss ₹13.8 Cr in Q1 FY26+267.0% vs Q4 FY26
Q1 FY27 revenue: ₹1,245 Cr+12.6% vs Q1 FY26+10.6% vs Q4 FY26
Q1 FY27 operating margin: 9.5%+8.2 pts vs Q1 FY26+9.0 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹16.3 CrRevenue ₹1,083 Cr
Q1 FY27 EPS (basic): ₹7.49

Questions

When will Gujarat Alkalies and Chemicals announce its Q2 FY27 results?

On 5 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 26 October 2026). Last year it reported Q2 FY26 on 7 November 2025.

What will Gujarat Alkalies and Chemicals' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹16.3 crore and revenue from operations ₹1,083 crore. The latest quarter, Q1 FY27, had a net profit of ₹55 crore and revenue of ₹1,245 crore.

What was Gujarat Alkalies and Chemicals' net profit in FY26?

Consolidated net profit was a loss of ₹2.4 crore in FY26 (April 2025–March 2026), narrower than the loss of ₹65.1 crore in FY25. It was a loss of ₹237 crore in FY24 and a profit of ₹410 crore in FY23.

What were Gujarat Alkalies and Chemicals' Q1 FY27 results?

Consolidated net profit was ₹55 crore, against a loss of ₹13.8 crore in Q1 FY26 and up 267.0% from ₹15 crore in Q4 FY26. Revenue from operations was ₹1,245 crore, up 12.6% year on year and up 10.6% from the previous quarter.

How has Gujarat Alkalies and Chemicals' profit changed over the last four quarters?

Net profit by quarter: a profit of ₹16.3 crore in Q2 FY26, a loss of ₹20 crore in Q3 FY26, a profit of ₹15 crore in Q4 FY26 and a profit of ₹55 crore in Q1 FY27. That is a combined profit of ₹66.4 crore over the four quarters. Revenue from operations: ₹1,083 crore, ₹1,044 crore, ₹1,125 crore and ₹1,245 crore.

What was Gujarat Alkalies and Chemicals' revenue in FY26?

Revenue from operations was ₹4,358 crore in FY26 (April 2025–March 2026), up 7.0% from ₹4,073 crore in FY25. It was ₹3,807 crore in FY24 and ₹4,517 crore in FY23: down 3.5% over three years, an average fall of 1.2% a year.

Where do these Gujarat Alkalies and Chemicals figures come from?

From Gujarat Alkalies and Chemicals' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.